ASO Author Reflections: Neoadjuvant Chemotherapy Prior to CRS/HIPEC for Metachronous Colorectal Peritoneal Metastases: No Survival Gain and Increased Perioperative Risk.

Saved in:
Bibliographic Details
Title: ASO Author Reflections: Neoadjuvant Chemotherapy Prior to CRS/HIPEC for Metachronous Colorectal Peritoneal Metastases: No Survival Gain and Increased Perioperative Risk.
Authors: Bank H; Department of Surgery, Massachusetts General Hospital, Boston, MA, USA., Wach MM; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL, USA., Ongchin M; Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA. ongchinmc3@upmc.edu.
Source: Annals of surgical oncology [Ann Surg Oncol] 2026 Jul; Vol. 33 (7), pp. 6198-6199. Date of Electronic Publication: 2026 Apr 22.
Publication Type: Journal Article
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1534-4681
DOI:10.1245/s10434-026-19646-6